1 in 8 Americans currently on GLP-1s
Approximately one in eight Americans is currently taking a GLP-1 drug, with Scott Galloway predicting that figure could eventually reach one in two.
Snapshot · Pivot
Starmer Resigns, Reflecting Pool Fiasco, and Amazon Dumps OpenAI Movie
Explore episode
Jun 23, 2026
Where this was said
GLP-1 Drugs: The Innovation With Only Good News
At 49:35 · chapter starts 48:00
The GLP-1 conversation starts as an aside about SpaceX shorts and longs — Scott says if he had to go long any category it would be GLP-1s — and quickly becomes one of the episode's most substantive health segments. New findings from the American Clinical Oncology gathering show that metastatic cancer growth rates are cut in half in patients on GLP-1s. Potential delays in dementia and Alzheimer's are also being studied. Kara discloses that her cardiologist has already recommended a low dose for her after her stroke. Scott notes that every new GLP-1 study comes back with positive news — which is almost unprecedented for any major medical innovation. Externalities are usually negative (chemo causes leukemia, Big Tech causes polarisation), but GLP-1s keep surprising researchers. Both hosts predict the drug will move from 1 in 8 Americans to eventually 1 in 2, citing shifts in food consumption toward proteins and the market disruption for snack brands.
GLP-1s: The Innovation With Only Positive Externalities
Every new study on GLP-1 drugs comes back positive. Data from the American Clinical Oncology gathering shows metastatic cancer growth rates are cut in half for patients on GLP-1s. Scott Galloway predicts 1 in 2 Americans will eventually be on some form of the drug.
GLP-1s cut metastatic cancer growth rates in half
New findings from the American Clinical Oncology gathering suggest GLP-1 drugs cut the growth rates of metastatic cancers in half, adding to a growing list of positive second-order effects.
Similar snapshots
More than 3 in 4 Americans report anxiety or depression
Mental health challenges are nearly universal — BetterHelp's own research found the majority of Americans experiencing symptoms right now.
Medicaid 5-year look-back rule
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
Pipe broke → hydrogen sulfide studio air
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Robot surgery: 10x less blood loss
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
115M US adults have prediabetes
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths: 110K to 80K to 70K
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
Men's overdose rate fell 27% in one year
Men's overdose death rate fell 27% in a single year, outpacing the 23% drop for women.
Ages 15–24 overdose deaths down 37%
The steepest decline in overdose deaths was among 15–24-year-olds, whose rate fell 37%.
Nurses walk miles per shift fetching items
Fei-Fei Li observed that on a given hospital shift, nurses walk miles just to fetch medicine and supplies, illustrating a clear use case for assistive robotics in healthcare.
